eXp World EXPI Market Impact Q4 2025 Below Expectations FHNH First reports no available quarterly earnings or revenue data for its Series H preferred shares Is Tarsus Pharmaceuticals TARS stock failing to hold levels Tarsus Pharmaceuticals posts wider than expected EPS loss